Skip to content

Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6

Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6 : a Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04731896
Enrollment
100
Registered
2021-02-01
Start date
2021-02-08
Completion date
2021-12-31
Last updated
2022-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor, Induced, Amniotomy

Keywords

labor, Amniotomy, induction

Brief summary

Labor induction is the stimulation of uterine contractions during pregnancy, before labor begins on its own to achieve a vaginal birth. A health care provider might recommend labor induction for various reasons: primarily when there's concern for a mother's health or a baby's health. Combined with oxytocin infusion, amniotomy is commonly used in the induction of labor. However the perfect timing of amniotomy is still unknown. The aim of this study is to determine whether the early amniotomy followed by oxytocin, or initiating induction of labor with oxytocin followed by late amniotomy, is effective to reach active phase of labor.

Interventions

PROCEDUREAmniotomy

artificial rupture of the amniotic sac

Sponsors

University Tunis El Manar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 48 Years
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years old * Full term (36 weeks and 3 days of gestation reached) * Singletion gestation in cephalic presentation * Bishop score of ≥ 6

Exclusion criteria

* Prior uterine surgery, previous cesarean section * Ruptured membranes * Spontaneous labor * Multifetal pregnancy * Dystocic presentation * Fetal head not fixed at pelvic brim * Macrosomia * Hydramnios * Severe fetal growth restriction * Major fetal anomaly * Women with HIV, hepatitis C, hepatitis B * Women with medical conditions contraindication to a vaginal delivery * Women with COVID-19 infection

Design outcomes

Primary

MeasureTime frameDescription
Time to active phase of laborAt deliveryTotal time from initiation oxytocin infusion to reaching 5 cm cervical dilation

Secondary

MeasureTime frameDescription
Cesarean delivery rateAt deliveryRate of cesarean section
Time to vaginal deliveryAt deliveryTotal time from initiation of labor induction to vaginal delivery
Maternal outcomesFrom inclusion to discharge, up to 2 weeksIntrapartum and postpartum fever, postpartum haemorrhage, chorioamnionitis, endometritis
Fetal and neonatal outcomeFrom inclusion to discharge, up to 2 weeksFetal distress, birth asphyxia, acidosis, sepsis

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026